<DOC>
	<DOCNO>NCT01925300</DOCNO>
	<brief_summary>This study designate evaluate pharmacokinetic interaction bisoprolol rosuvastatin healthy male volunteer .</brief_summary>
	<brief_title>Pharmacokinetic Interactions Bisoprolol Rosuvastatin</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<criteria>Male volunteer age 20 55 year old ( inclusive ) Body mass index ( BMI ) range 18.5 27 kg/m2 ( inclusive ) Medically healthy clinically significant vital sign ( sit position blood pressure , pulse rate ) ( 90 mmHg ≤ systolic blood pressure ≤ 150 mmHg , 60 mmHg ≤ diastolic blood pressure ≤ 100 mmHg , 50 beat per minute ≤ pulse rate ≤ 100 beat per minute ) Available entire study period Understand requirement study voluntarily consent participate study Subjects history gastrointestinal disease might significantly change ADME ( Absorption , Distribution , Metabolism Excretion ) medicine History clinically significant arrhythmic , peripheral vascular , thyroid , bronchospasm , asthma disease Subjects anaphylaxis bisoprolol and/or rosuvastatin History drug abuse History caffeine , alcohol , smoke abuse caffeine ( coffee , tea , coke ) grapefruit juice &gt; 4cups/day smoking &gt; 20 cigarettes/day alcohol &gt; 140g/week Clinical laboratory test value outside accept normal range AST ( Aspartate Transaminase ) , ALT ( ALanine Transaminase ) ( &gt; 1.5 time normal range CK ( Creatine Kinase ) &gt; 1.5 time normal range Estimated GFR ( Glomerular Filtration Rate ) &lt; 60 mL/min Subjects whole blood donation within 60days , component blood donation within 30days blood transfusion within 30days prior study medication dose Subjects consider unsuitable base medical judgement investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
</DOC>